Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials
Nosocomial bacterial infections are associated with high morbidity and mortality, posing a huge burden to healthcare systems worldwide. The ongoing COVID-19 pandemic, with the raised hospitalization of patients and the increased use of antimicrobial agents, boosted the emergence of difficult-to-trea...
Main Authors: | Sílvia A. Sousa, Joana R. Feliciano, Tiago Pita, Catarina F. Soeiro, Beatriz L. Mendes, Luis G. Alves, Jorge H. Leitão |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/8/942 |
Similar Items
-
Antimicrobial peptides: new hope in the war against multidrug resistance
by: James Mwangi, et al.
Published: (2019-11-01) -
Towards Robust Delivery of Antimicrobial Peptides to Combat Bacterial Resistance
by: Matthew Drayton, et al.
Published: (2020-07-01) -
Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
by: Kaitlin S. Witherell, et al.
Published: (2020-09-01) -
Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
by: Pooi Yin Chung, et al.
Published: (2017-08-01) -
Antimicrobial Resistance of Nosocomial Infections in Children
by: Herry Garna
Published: (2019-01-01)